Intensified and multifaceted treatment of patients with type 2 diabetes and poor prognosis due to microalbuminuria extends median lifetime by 8 years compared with conventional therapy, according to a new long-term Danish follow-up study of the Steno-2 trial.
A Scottish study shows that the overall incidence of type 2 diabetes has stabilised over the past 12 years while mortality has declined. The study authors suggest that the increasing prevalence of the disease, from 3.2% in 2004 to 5.1% in 2013 is due to longer survival of patients and not increasing numbers.
A meta-analysis of 189 studies including 3.9 million adults across four continents shows that being overweight or obese is associated with an increased risk of premature death. The risks of coronary heart disease, stroke, respiratory disease and cancer are all increased.
This month’s Back to Basics feature is a wallchart showing the new government Eatwell Guide to help your patients understand how to eat a healthy and balanced diet. You may also be interested in visiting the Eatwell page on the NHS Choices website. This includes useful healthy eating tools such as a calorie checker and BMI calculator.
A recent systematic review and meta-analysis of 10 double-blind randomised controlled studies including 6456 people has found that adding a DPP-4 inhibitor (or gliptin) to a sulfonylurea increases the risk of hypoglycaemia by about 50%.
People at high risk of developing Type 2 diabetes can reduce their chances of getting the condition by more than 80% by completing a new education programme, according to a new study from the Leicester Diabetes Centre.
A large international study (INTERSTROKE) in 27,000 patients highlights the importance of managing hypertension and other modifiable risk factors in stroke prevention. A total of 90% of the risk of stroke is accounted for by 10 modifiable risk factors.